Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Translational Andrology and Urology is Scopus-indexed (Q3, CiteScore 2.4), WoS SCIE. Published by AME Publishing Company.
Checked against the index lists dated .
ISSN 2223-4683Verify ISSN ↗2223-4691Verify ISSN ↗
Publisher: AME Publishing Company
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Urology | 63 / 123 | 49th | Q3 |
| Reproductive Medicine | 56 / 99 | 43rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q3, CiteScore 2.4.
Translational Andrology and Urology is Q3 in Urology (rank 63 of 123) and Q3 in Reproductive Medicine (rank 56 of 99), by CiteScore 2025.
Translational Andrology and Urology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.4, which places it in quartile Q3 at the 49th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.505, quartile Q2, with an H-index of 62.
Translational Andrology and Urology is published by AME Publishing Company. Its print ISSN is 2223-4683 and its online ISSN is 2223-4691.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Translational Andrology and Urology has an h-index of 64 and a 2-year mean of 1.83 citations per paper (OpenAlex). Its Scopus CiteScore is 2.4, quartile Q3. On 2-year citations it ranks #41 of 123 Scopus journals in Urology.
Translational Andrology and Urology published 372 papers in 2025; its busiest recent year was 2017 with 459. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (55.6%), United States (16.3%) and Japan (6.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.